Cargando…
Challenges in Development of Nanoparticle-Based Therapeutics
In recent years, nanotechnology has been increasingly applied to the area of drug development. Nanoparticle-based therapeutics can confer the ability to overcome biological barriers, effectively deliver hydrophobic drugs and biologics, and preferentially target sites of disease. However, despite the...
Autor principal: | Desai, Neil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326161/ https://www.ncbi.nlm.nih.gov/pubmed/22407288 http://dx.doi.org/10.1208/s12248-012-9339-4 |
Ejemplares similares
-
Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges
por: Zhou, Jiehua, et al.
Publicado: (2013) -
Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities
por: Yang, Pingping, et al.
Publicado: (2023) -
Toward the Development of Epigenome Editing-Based Therapeutics: Potentials and Challenges
por: Ueda, Jun, et al.
Publicado: (2023) -
The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson’s Disease
por: Titze-de-Almeida, Simoneide S., et al.
Publicado: (2020) -
Critical questions in development of targeted nanoparticle therapeutics
por: Korsmeyer, Richard
Publicado: (2016)